Cite
HARVARD Citation
Harris, T. et al. (n.d.). P2 Evaluation of Switching Therapy from Fixed-Dose Combination Inhaled Corticosteroid/Long-Acting Beta2agonist to Beclometasone Dipropionate/Formoterol (Fostair 100/6®). Thorax. pp. A64-A65. [Online].